ARCHIVES

Regulatory Approvals: FDA expanded the approved use of Cyramza to include metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 40 No. 47 | December 19, 2014

Download PDF Visit The Full Archive

Related Articles

NCI, CCSG Collaborating On Electromagnetic Field Exposure Study

April 6, 1990

Drugs Available To Investigators Centers to Monitor Them Are Listed

September 9, 1977

NCI-Approved Clinical Trials

January 26, 2007

In Brief: DCPC Still Looking For Yates’ Replacement New jersey Commission Offers New Fellowships

December 4, 1987

Next Bypass Budget: Slim, Trim, Modest

September 15, 1995

ASCO Breaks Ground For New HQ.

August 4, 2006